Extensive cross-reactive neutralizing antibody response in Indian patients with limited genetic diversity of HIV-1

Virology

Volumn 359, Issue 2, 2007, Pages 295-301

  Lakhashe, Samir K ^a   Kulkarni, Smita S ^a   Thakar, Madhuri R ^a   Ghate, Manisha V ^a   Paranjape, Ramesh S ^a  

^a NATIONAL AIDS RESEARCH INSTITUTE   (India)

Author keywords

Cross neutralization; Genetic diversity; HIV subtype C; India

Indexed keywords

CD4 ANTIGEN; CROSS REACTING ANTIBODY; NEUTRALIZING ANTIBODY;

ANTIBODY RESPONSE; ARTICLE; BLOOD SAMPLING; FEMALE; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 SUBTYPE C; HUMAN TISSUE; INDIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VIRUS ISOLATION; VIRUS TYPING;

ANTIBODIES, VIRAL; CROSS REACTIONS; FEMALE; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; INDIA; MALE; NEUTRALIZATION TESTS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33847218005     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.09.019     Document Type: Article

References (29)

1. Agnihotri A., Srikanth T., Abhay J., Sushama J., Swarali K., and Ramesh P. gp120 sequences from HIV type 1 subtype C early seroconverters in India. AIDS Res. Hum. Retrovir. 20 8 (2004) 889-894
2. Agnihotri K.D., Tripathy S.P., Jere A.P., Kale S.M., and Paranjape R.S. Molecular analysis of gp41 sequences of HIV type 1 subtype C from India. J. Acquir. Immune Defic. Syndr. 41 3 (2006) 345-351
3. Binley J.M., Wrin T., Korber B., Zwick M.B., Wang M., Chappey C., Stiegler G., Kunert R., Zolla-Pazner S., Katinger H., Petropoulos C.J., and Burton D.R. Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies. J. Virol. 78 23 (2004) 13232-13252
4. Bures R., Morris L., Williamson C., Ramjee G., Deers M., Fiscus S.A., Abdool-Karim S., and Montefiori D.C. Regional clustering of shared neutralization determinants on primary isolates of clade C human immunodeficiency virus type 1 from South Africa. J. Virol. 76 5 (2002) 2233-2244
5. Cao Y., Qin L., Zhang L., Safrit J., and Ho D.D. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N. Engl. J. Med. 332 4 (1995) 201-208
6. Carotenuto P., Looij D., Keldermans L., de Wolf F., and Goudsmit J. Neutralizing antibodies are positively associated with CD4+ T-cell counts and T-cell function in long-term AIDS-free infection. AIDS 12 13 (1998) 1591-1600
7. Cecilia D., Kulkarni S.S., Tripathy S.P., Gangakhedkar R.R., Paranjape R.S., and Gadkari D.A. Absence of coreceptor switch with disease progression in human immunodeficiency virus infections in India. Virology 271 2 (2000) 253-258
8. Choudhury S., Montano M.A., Womack C., Blackard J.T., Maniar J.K., Saple D.G., Tripathy S., Sahni S., Shah S., Babu G.P., and Essex M. Increased promoter diversity reveals a complex phylogeny of human immunodeficiency virus type 1 subtype C in India. J. Hum. Virol. 3 1 (2000) 35-43
9. Derdeyn C.A., Decker J., Bibollet-Ruche M., Mokili F., Muldoon J.L., Denham M., Heil S.A., Kasolo M.L., Musonda F., Hahn R., Shaw B.H., Korber G.M., Allen B.T., and Hunter S. Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission. Science 303 5666 (2004) 2019-2022
10. Eshleman S.H., Hudelson S.E., Gupta A., Bollinger R., Divekar A.D., Gangakhedkar R.R., Kulkarni S.S., Thakar M.R., Paranjape R.S., and Tripathy S. Limited evolution in the HIV type 1 pol region among acute seroconverters in Pune, India. AIDS Res. Hum. Retrovir. 21 1 (2005) 93-97
11. Gaschen B., Taylor J., Yusim K., Foley B., Gao F., Lang D., Novitsky V., Haynes B., Hahn B.H., Bhattacharya T., and Korber B. Diversity considerations in HIV-1 vaccine selection. Science 296 5577 (2002) 2354-2360
12. Gupta R.M., Prasad V.V., Rai A., and Seth P. Analysis of HIV type 1 subtype C full-length gag gene sequences from India: novel observations and plausible implications. AIDS Res. Hum. Retrovir. 21 12 (2005) 1066-1072
13. Jere A., Tripathy S., Agnihotri K., Jadhav S., and Paranjape R. Genetic analysis of Indian HIV-1 nef: subtyping, variability and implications. Microbes Infect. 6 3 (2004) 279-289
14. Kulkarni S., Sane S., Tondare P., Dhande K., Jadhav S., Tripathy S., Bollinger R., and Paranjape R. Neutralizing antibody responses in recent seroconverters with subtype C infections in India. AIDS Vaccine 2005 International Conference, Montreal, Canada (2005)
15. Kurle S., Tripathy S., Jadhav S., Agnihotri K., and Paranjape R. Full-length gag sequences of HIV type 1 subtype C recent seroconverters from Pune, India. AIDS Res. Hum. Retrovir. 20 10 (2004) 1113-1118
16. Mascola J.R. Defining the protective antibody response for HIV-1. Curr. Mol. Med. 3 3 (2003) 209-216
17. Moog C., Fleury H.J., Pellegrin I., Kirn A., and Aubertin A.M. Autologous and heterologous neutralizing antibody responses following initial seroconversion in human immunodeficiency virus type 1-infected individuals. J. Virol. 71 5 (1997) 3734-3741
18. Nishimura Y., Igarashi T., Haigwood N., Sadjadpour R., Plishka R.J., Buckler-White A., Shibata R., and Martin M.A. Determination of a statistically valid neutralization titer in plasma that confers protection against simian-human immunodeficiency virus challenge following passive transfer of high-titered neutralizing antibodies. J. Virol. 76 5 (2002) 2123-2130
19. Novitsky V.A., Montano M.A., McLane M.F., Renjifo B., Vannberg F., Foley B.T., Ndung'u T.P., Rahman M., Makhema M.J., Marlink R., and Essex M. Molecular cloning and phylogenetic analysis of human immunodeficiency virus type 1 subtype C: a set of 23 full-length clones from Botswana. J. Virol. 73 5 (1999) 4427-4432
20. Novitsky V., Smith U.R., Gilbert P., McLane M.F., Chigwedere P., Williamson C., Ndung'u T., Klein I., Chang S.Y., Peter T., Thior I., Foley B.T., Gaolekwe S., Rybak N., Gaseitsiwe S., Vannberg F., Marlink R., Lee T.H., and Essex M. Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?. J. Virol. 76 11 (2002) 5435-5451
21. Paranjape R.S., Gadkari D.A., Lubaki M., Quinn T.C., and Bollinger R.C. Cross-reactive HIV-1-specific CTL in recent seroconverters from Pune, India. Indian J. Med. Res. 108 (1998) 35-41
22. Pilgrim A.K., Pantaleo G., Cohen O.J., Fink L.M., Zhou J.Y., Zhou J.T., Bolognesi D.P., Fauci A.S., and Montefiori D.C. Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection. J. Infect. Dis. 176 4 (1997) 924-932
23. Shankarappa R., Chatterjee R., Learn G.H., Neogi D., Ding M., Roy P., Ghosh A., Kingsley L., Harrison L., Mullins J.I., and Gupta P. Human immunodeficiency virus type 1 env sequences from Calcutta in eastern India: identification of features that distinguish subtype C sequences in India from other subtype C sequences. J. Virol. 75 21 (2001) 10479-10487
24. Thakar M.R., Patke D., Lakhashe S.K., Bhonge L., Kulkarni S.V., Tripathy S.P., Gupte N., Brookmeyer R., Quinn T.C., Paranjape R.S., and Bollinger R.C. Consistent subtype-specific anti-HIV type 1 T lymphocyte responses in Indian subjects recently infected with HIV type 1. AIDS Res. Hum. Retrovir. 18 18 (2002) 1389-1393
25. Thakar M.R., Bhonge L.S., Lakhashe S.K., Shankarkumar U., Sane S.S., Kulkarni S.S., Mahajan B.A., and Paranjape R.S. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef. J. Infect. Dis. 192 5 (2005) 749-759
26. Trkola A., Ketas T., Kewalramani V.N., Endorf F., Binley J.M., Katinger H., Robinson J., Littman D.R., and Moore J.P. Neutralization sensitivity of human immunodeficiency virus type 1 primary isolates to antibodies and CD4-based reagents is independent of coreceptor usage. J. Virol. 72 3 (1998) 1876-1885
27. Wei X., Decker J.M., Wang S., Hui H., Kappes J.C., Wu X., Salazar-Gonzalez J.F., Salazar M.G., Kilby J.M., Saag M.S., Komarova N.L., Nowak M.A., Hahn B.H., Kwong P.D., and Shaw G.M. Antibody neutralization and escape by HIV-1. Nature 422 6929 (2003) 307-312
28. Wrin T., Crawford L., Sawyer L., Weber P., Sheppard H.W., and Hanson C.V. Neutralizing antibody responses to autologous and heterologous isolates of human immunodeficiency virus. J. Acquir. Immune Defic. Syndr. 7 3 (1994) 211-219
29. Zhang Y.J., Fracasso C., Fiore J.R., Bjorndal A., Angarano G., Gringeri A., and Fenyo E.M. Augmented serum neutralizing activity against primary human immunodeficiency virus type 1 (HIV-1) isolates in two groups of HIV-1-infected long-term nonprogressors. J. Infect. Dis. 176 5 (1997) 1180-1187